Vanberra Signal

GenomOncology

Curated by Signal

Developer of precision medicine by transforming genomic data into actionable information

Overview

GenomOncology is a healthcare technology company enabling precision medicine by transforming genomic data into actionable information. It has developed a proprietary technology platform to streamline the use of next-generation sequencing in medicine and research. Precision Medicine Portfolio is a suite of products and services that addresses for precision medicine in molecular pathology and medical genetics, particularly in the field of oncology and other hereditary diseases. This portfolio supports test validation and production, clinical decision support, and analytics for both monitoring and discovery. Its other products include the GO Validation Toolkit, the GO Clinical Workbench, and GenomAnalytics. It also offers scientific services like test validation, customization, integration, and research.

Key facts

Founded
2012

Business model

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of online information on women pelvic and urinary incontinence health-related problems

    Health TechnologyUnited States
  • Developer of cannabidiol extract-based supplements

    Health TechnologyCave Creek, United States
  • Provider of an app for managing epilepsy for doctors and patients

    Health TechnologyHouston, United States

About GenomOncology

What does GenomOncology do?

GenomOncology is a healthcare technology company enabling precision medicine by transforming genomic data into actionable information.

Where is GenomOncology headquartered?

GenomOncology is headquartered in Cleveland, United States.

When was GenomOncology founded?

GenomOncology was founded in 2012.

Which sector is GenomOncology in?

GenomOncology operates in Health Technology.

Who are GenomOncology's competitors?

Companies similar to GenomOncology include Femalepelvicsolutions.net, CBD Unlimited, and Epsy.